Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification

Area of Science:

• Oncology
• Endocrinology
• Genetics

Background:

• Papillary thyroid carcinoma is the predominant thyroid malignancy in adults and children.
• Changes in diagnostic criteria and rising incidence rates worldwide, particularly for papillary thyroid carcinoma, are observed.
• Established risk factors include radiation exposure, with other environmental factors like iodine, obesity, and pollutants also implicated.

Purpose of the Study:

• To review the epidemiology, risk factors, and diagnostic markers of papillary thyroid carcinoma.
• To discuss the implications of genetic mutations, such as BRAF, in sporadic cases.
• To highlight the importance of understanding clinical, pathological, and molecular parameters for patient management.

Main Methods:

• Literature review of epidemiological trends and risk factors for papillary thyroid carcinoma.
• Analysis of diagnostic criteria evolution and classification changes.
• Examination of genetic mutations (germline and somatic) associated with papillary thyroid carcinoma.

Main Results:

• Papillary thyroid carcinoma incidence is increasing globally, driven by diagnostic changes and environmental factors.
• BRAF mutations are frequent in sporadic cases and correlate with prognostic markers.
• Familial cases show a 5% rate of well-studied driver germline mutations.

Conclusions:

• Papillary thyroid carcinoma management requires awareness of clinical, pathological, and molecular features.
• While prognosis is generally good, recurrence and secondary cancers necessitate ongoing monitoring.
• Further research is needed to fully understand the multifactorial reasons behind the rising incidence.